ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

February 3, 1995

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991

Centers, Cancer Control Would Get Larger Shares of NCI Increase In House Bill; Grant Total Drops

August 28, 1987

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993